IP Library Granted Patent US 9,534,251
Granted Patent B2
US 9,534,251 · App. 12/750,571 · Granted Jan 3, 2017

In vitro recombination method

Inventors: Lei Young (Gaithersburg, MD); Hamilton O. Smith (San Diego, CA); Daniel Glenn Gibson (Crofton, MD)
Assignee: Synthetic Genomics, Inc.
C12Q1/6862C12N15/10C12N15/64C12N15/66C12P19/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,534,251
App. No.
12/750,571
Granted
Jan 3, 2017
Kind
B2
Abstract

The present invention relates, e.g., to in vitro method, using isolated protein reagents, for joining two double stranded (ds) DNA molecules of interest, wherein the distal region of the first DNA molecule and the proximal region of the second DNA molecule share a region of sequence identity, comprising contacting the two DNA molecules in a reaction mixture with (a) a non-processive 5′ exonuclease; (b) a single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing; (c) a non strand-displacing DNA polymerase; and (d) a ligase, under conditions effective to join the two DNA molecules to form an intact double stranded DNA molecule, in which a single copy of the region of sequence identity is retained. The method allows the joining of a number of DNA fragments, in a predetermined order and orientation, without the use of restriction enzymes.

Claims (34)

1. A kit for in vitro joining a plurality of dsDNA molecules, consisting essentially of in a single container,

a mixture of the isolated proteins

(i) a single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing,

(ii) a non strand-displacing DNA polymerase, and

(iii) a ligase;

(iv) an isolated non-processive 5′ exonuclease; and

(v) glycerol in an amount effective as a preservative;

wherein the ratios of activities of (i), (ii), (iii), and (iv) are effective to achieve in vitro joining of dsDNA molecules, and

wherein the dsDNA molecules are joined via a region of sequence homology to form a DNA molecule in which a single copy of the region of sequence homology is retained.

2. The kit of claim 1 , wherein

the mixture contains

(i) as the SSB, the phage T7 gene 2.5 product, the E. coli recA protein, RedB of lambda phage, or RecT of Rae prophage;

(ii) as the DNA polymerase, the T7 gene 5 product, T4 polymerase, or E. coli pol; and/or

(iii) as the ligase, the phage T7 gene 1.3 product, phage T4 DNA ligase, or E. coli DNA ligase; and/or

(iv) as the 5′ exonuclease, the phage T7 gene 6 product, RedA of lambda phage, or RecE of Rae prophage.

3. The kit of claim 2 wherein:

(i) the phage T7 gene 2.5 product, the E. coli recA protein, RedB of lambda phage, or RecT of Rae prophage are substantially purified;

(ii) the T7 gene 5 product, T4 polymerase, or E. coli pol are substantially purified; and/or

(iii) the phage T7 gene 1.3 product, phage T4 DNA ligase, or E. coli DNA ligase are substantially purified.

4. The kit of claim 3 wherein the non-processive 5′ exonuclease is substantially purified.

5. The kit of claim 3 further comprising instructions for performing a method for the in vitro joining of a plurality of dsDNA molecules.

6. The kit of claim 1 wherein:

(i) the single stranded DNA binding protein (SSB) is substantially purified;

(ii) the non strand-displacing DNA polymerase is substantially purified, and

(iii) the ligase is substantially purified.

7. The kit of claim 6 wherein the non-processive 5′ exonuclease is substantially purified.

8. The kit of claim 6 further comprising instructions for performing a method for the in vitro joining of a plurality of dsDNA molecules.

9. A composition consisting essentially of:

(a) a substantially purified single stranded DNA binding protein (SSB) which accelerates nucleic acid annealing,

(b) a substantially purified non strand-displacing DNA polymerase,

(c) a substantially purified ligase, and

(d) substantially purified non-processive 5′ exonuclease, and

(e) glycerol in an amount effective as a preservative;

wherein the ratios of activities of (a), (b), (c) and (d) are effective to achieve in vitro joining of dsDNA molecules via a region of homology.

Assignments (10)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (TERM) Recorded Jul 16, 2024
From: MIDCAP FINANCIAL TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0070 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY (REVOLVING) Recorded Jul 16, 2024
From: MIDCAP FUNDING IV TRUST
To: TELESIS BIO INC. (FORMERLY KNOWN AS CODEX DNA, INC.); ETONBIO, INC.
Reel/Frame 068390/0001 →
CHANGE OF NAME Recorded Apr 19, 2023
From: CODEX DNA, INC.
To: TELESIS BIO INC.
Reel/Frame 063379/0581 →
SECURITY INTEREST (REVOLVING) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 061208/0063 →
SECURITY INTEREST (TERM) Recorded Aug 18, 2022
From: CODEX DNA, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061208/0080 →
RELEASE OF SECURITY INTEREST Recorded Nov 10, 2020
From: OXFORD FINANCE LLC
To: SYNTHETIC GENOMICS, INC.; GENOVIA BIO, LLC; GREEN RESOURCES, LLC; SGI-DNA, INC.; SYNTHETIC GENOMICS VACCINES, INC.
Reel/Frame 054372/0822 →
CHANGE OF NAME Recorded May 19, 2020
From: SGI-DNA, INC.
To: CODEX DNA, INC.
Reel/Frame 052705/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2019
From: SYNTHETIC GENOMICS, INC.
To: SGI-DNA, INC.
Reel/Frame 049602/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2010
From: YOUNG, LEI; GIBSON, DANIEL G.; SMITH, HAMILTON O.
To: J. CRAIG VENTER INSTITUTE, INC.
Reel/Frame 024408/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2010
From: J. CRAIG VENTER INSTITUTE, INC.
To: SYNTHETIC GENOMICS, INC.
Reel/Frame 024408/0801 →
Continuity (3)
Division 11502746 · Aug 11, 2006
Provisional Application 60707160 · Aug 11, 2005
Related Publication 20100184187A1 · Jul 22, 2010